The Mystery of Futility of Appropriate Antibiotics for Coinfection in COVID-19.
作者信息
Kasugai Daisuke, Jingushi Naruhiro, Omote Norihiro, Shindo Yuichiro, Goto Yukari
机构信息
Nagoya University Graduate School of Medicine Nagoya, Japan.
出版信息
Am J Respir Crit Care Med. 2021 Dec 15;204(12):1489. doi: 10.1164/rccm.202107-1656LE.
Abstract
摘要
相似文献
1
The Mystery of Futility of Appropriate Antibiotics for Coinfection in COVID-19.
Am J Respir Crit Care Med. 2021 Dec 15;204(12):1489. doi: 10.1164/rccm.202107-1656LE.
2
Reply to Kasugai : The Mystery of Futility of Appropriate Antibiotics for Coinfection in COVID-19.
Am J Respir Crit Care Med. 2021 Dec 15;204(12):1489-1491. doi: 10.1164/rccm.202108-1846LE.
3
COVID-19 pneumonia and the appropriate use of antibiotics.
Lancet Glob Health. 2020 Dec;8(12):e1453-e1454. doi: 10.1016/S2214-109X(20)30444-7. Epub 2020 Nov 11.
4
Appropriate use of antimicrobial therapy for COVID-19 co-infection.
Immunotherapy. 2021 Sep;13(13):1067-1070. doi: 10.2217/imt-2021-0134. Epub 2021 Jun 11.
5
Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics.
J Infect. 2020 Sep;81(3):e29-e30. doi: 10.1016/j.jinf.2020.06.077. Epub 2020 Jul 3.
6
Antimicrobial Stewardship in a Pandemic: Picking Up the Pieces.
Clin Infect Dis. 2021 May 18;72(10):e542-e544. doi: 10.1093/cid/ciaa1273.
7
Could the COVID-19 pandemic aggravate antimicrobial resistance?
Am J Infect Control. 2020 Sep;48(9):1129-1130. doi: 10.1016/j.ajic.2020.06.192. Epub 2020 Jun 27.
8
The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19.
Chest. 2021 Aug;160(2):387-388. doi: 10.1016/j.chest.2021.04.053.
9
Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients.
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0134121. doi: 10.1128/AAC.01341-21. Epub 2021 Sep 7.
10
Improving Antimicrobial Stewardship in Critically-Ill Patients with COVID-19.
Clin Infect Dis. 2021 Jun 1;72(11):e926. doi: 10.1093/cid/ciaa1559.
引用本文的文献
1
The Impact of Early Antibiotic Use on Clinical Outcomes of Patients Hospitalized with COVID-19: A Propensity Score-Matched Analysis.
Infect Drug Resist. 2024 Aug 9;17:3425-3438. doi: 10.2147/IDR.S470957. eCollection 2024.
本文引用的文献
1
Early Bacterial Identification among Intubated Patients with COVID-19 or Influenza Pneumonia: A European Multicenter Comparative Clinical Trial.
Am J Respir Crit Care Med. 2021 Sep 1;204(5):546-556. doi: 10.1164/rccm.202101-0030OC.
2
Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact?
Crit Care. 2021 Apr 21;25(1):153. doi: 10.1186/s13054-021-03571-z.
3
COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.
Intensive Care Med. 2021 Feb;47(2):180-187. doi: 10.1007/s00134-021-06346-w. Epub 2021 Jan 27.
4
Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study.
Intensive Care Med. 2021 Feb;47(2):188-198. doi: 10.1007/s00134-020-06323-9. Epub 2021 Jan 3.
5
Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study.
Lancet Infect Dis. 2015 Sep;15(9):1055-1065. doi: 10.1016/S1473-3099(15)00151-6. Epub 2015 Jul 2.
Zotero 插件